ICYMI: A patient, physician, biotech investor and industry leaders warn about the dangers of government price setting bill

During a widely attended media briefing, physicians, biopharmaceutical leaders, and a brave cancer survivor, all expressed their strong opposition to the extreme drug pricing bill Congress is currently considering. They explained why allowing the government to set the price for lifesaving medicines will decimate the hope of curing cancer and other deadly diseases and why policymakers should start over with a new bipartisan approach that lowers costs and protects future innovation.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Research and Development Economic Impact Patients Government Price Setting Source Type: news